carbamates and salmeterol xinafoate

carbamates has been researched along with salmeterol xinafoate in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baggen, S; Chan, R; Locantore, N; Ludwig-Sengpiel, A; Riley, JH; Wielders, PL	1
Ambery, C; Bateman, ED; Kornmann, O; Norris, V	1
Chen, Y; Hegde, SS; Hughes, AD; Jasper, JR; Lee, TW; Mammen, M; Martin, WJ; McNamara, A; Pulido-Rios, MT; Steinfeld, T	1
Marshall, G	1

Trials

2 trial(s) available for carbamates and salmeterol xinafoate

Article	Year
A new class of bronchodilator improves lung function in COPD: a trial with GSK961081. The European respiratory journal, 2013, Volume: 42, Issue:4 Topics: Aged; Albuterol; Bronchodilator Agents; Carbamates; Double-Blind Method; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Safety; Pulmonary Disease, Chronic Obstructive; Quinolones; Salmeterol Xinafoate; Smoking; Spirometry; Treatment Outcome	2013
Pharmacodynamics of GSK961081, a bi-functional molecule, in patients with COPD. Pulmonary pharmacology & therapeutics, 2013, Volume: 26, Issue:5 Topics: Adrenergic beta-2 Receptor Agonists; Adult; Aged; Albuterol; Bronchodilator Agents; Carbamates; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinolones; Salmeterol Xinafoate; Scopolamine Derivatives; Time Factors; Tiotropium Bromide; Treatment Outcome	2013

Article

Year

A new class of bronchodilator improves lung function in COPD: a trial with GSK961081.

The European respiratory journal, 2013, Volume: 42, Issue:4

Topics: Aged; Albuterol; Bronchodilator Agents; Carbamates; Double-Blind Method; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Muscarinic Antagonists; Patient Safety; Pulmonary Disease, Chronic Obstructive; Quinolones; Salmeterol Xinafoate; Smoking; Spirometry; Treatment Outcome

2013

Pharmacodynamics of GSK961081, a bi-functional molecule, in patients with COPD.

Pulmonary pharmacology & therapeutics, 2013, Volume: 26, Issue:5

Topics: Adrenergic beta-2 Receptor Agonists; Adult; Aged; Albuterol; Bronchodilator Agents; Carbamates; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinolones; Salmeterol Xinafoate; Scopolamine Derivatives; Time Factors; Tiotropium Bromide; Treatment Outcome

2013

Other Studies

2 other study(ies) available for carbamates and salmeterol xinafoate

Article	Year
Pharmacologic characterization of GSK-961081 (TD-5959), a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties. The Journal of pharmacology and experimental therapeutics, 2014, Volume: 351, Issue:1 Topics: Adrenergic beta-2 Receptor Antagonists; Albuterol; Animals; Bronchodilator Agents; Carbamates; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Drug Evaluation, Preclinical; Guinea Pigs; HEK293 Cells; Humans; Lung; Muscarinic Antagonists; Muscle Relaxation; Muscle, Smooth; Protein Binding; Quinolones; Receptors, Adrenergic, beta; Receptors, Muscarinic; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide; Tissue Distribution; Trachea	2014
Falling up stairs. Australian family physician, 2016, Volume: 45, Issue:9 Topics: 2-Naphthylamine; Accidental Falls; Anilides; Antiviral Agents; Bronchodilator Agents; Carbamates; Cushing Syndrome; Cyclopropanes; Drug Therapy, Combination; Fluticasone; Hepatitis C; Humans; Hydrocortisone; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Ritonavir; Salmeterol Xinafoate; Sulfonamides; Uracil; Valine	2016

Article

Year

Pharmacologic characterization of GSK-961081 (TD-5959), a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties.

The Journal of pharmacology and experimental therapeutics, 2014, Volume: 351, Issue:1

Topics: Adrenergic beta-2 Receptor Antagonists; Albuterol; Animals; Bronchodilator Agents; Carbamates; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Drug Evaluation, Preclinical; Guinea Pigs; HEK293 Cells; Humans; Lung; Muscarinic Antagonists; Muscle Relaxation; Muscle, Smooth; Protein Binding; Quinolones; Receptors, Adrenergic, beta; Receptors, Muscarinic; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide; Tissue Distribution; Trachea

2014

Falling up stairs.

Australian family physician, 2016, Volume: 45, Issue:9

Topics: 2-Naphthylamine; Accidental Falls; Anilides; Antiviral Agents; Bronchodilator Agents; Carbamates; Cushing Syndrome; Cyclopropanes; Drug Therapy, Combination; Fluticasone; Hepatitis C; Humans; Hydrocortisone; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Ritonavir; Salmeterol Xinafoate; Sulfonamides; Uracil; Valine

2016